Skip to content

Released May 12, 2022, after the close

10-Q filed May 12, 2022, 42 days after period end · 0001564590-22-019879

Q1 2022 · 10-Q
Revenue—
Net Income-$23.09MN/M vs Q1 2021N/M vs Q4 2021
EPS Diluted-$0.48N/M vs Q1 2021no prior Q4 2021 on file
Operating Income-$23,162,000N/M
Operating Cash Flow-$27,502,000N/M
Free Cash Flowderived-$27,502,000N/M

What the release said

The release

Same quarter

MetricQ1 2022Q1 2021Q1 2020Q1 2019
Revenue——$4.08M$3.89M
Net Income-$23.09M-$27.20M-$26.66M-$27.05M
EPS Diluted-$0.48-$0.69-$0.76-$1.05

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Assembly Biosciences, Inc. · CIK 1426800 · Engraved from SEC EDGAR